Your browser doesn't support javascript.
loading
CD8 T-cell responses against the immunodominant Theileria parva peptide Tp249-59 are composed of two distinct populations specific for overlapping 11-mer and 10-mer epitopes.
Connelley, Timothy K; Li, Xiaoying; MacHugh, Niall; Colau, Didier; Graham, Simon P; van der Bruggen, Pierre; Taracha, Evans L; Gill, Andy; Morrison, William Ivan.
Afiliación
  • Connelley TK; Division of Immunity and Infection, The Roslin Institute, The University of Edinburgh, Midlothian, UK.
  • Li X; Division of Immunity and Infection, The Roslin Institute, The University of Edinburgh, Midlothian, UK.
  • MacHugh N; Division of Immunity and Infection, The Roslin Institute, The University of Edinburgh, Midlothian, UK.
  • Colau D; Ludwig Institute for Cancer Research and de Duve Institute, Universite catholique de Louvain, Brussels, Belgium.
  • Graham SP; The International Livestock Research Institute, Nairobi, Kenya.
  • van der Bruggen P; Ludwig Institute for Cancer Research and de Duve Institute, Universite catholique de Louvain, Brussels, Belgium.
  • Taracha EL; The International Livestock Research Institute, Nairobi, Kenya.
  • Gill A; Division of Neurobiology, The Roslin Institute, The University of Edinburgh, Midlothian, UK.
  • Morrison WI; Division of Immunity and Infection, The Roslin Institute, The University of Edinburgh, Midlothian, UK.
Immunology ; 149(2): 172-85, 2016 10.
Article en En | MEDLINE | ID: mdl-27317384
Immunity against Theileria parva is associated with CD8 T-cell responses that exhibit immunodominance, focusing the response against limited numbers of epitopes. As candidates for inclusion in vaccines, characterization of responses against immunodominant epitopes is a key component in novel vaccine development. We have previously demonstrated that the Tp249-59 and Tp1214-224 epitopes dominate CD8 T-cell responses in BoLA-A10 and BoLA-18 MHC I homozygous animals, respectively. In this study, peptide-MHC I tetramers for these epitopes, and a subdominant BoLA-A10-restricted epitope (Tp298-106 ), were generated to facilitate accurate and rapid enumeration of epitope-specific CD8 T cells. During validation of these tetramers a substantial proportion of Tp249-59 -reactive T cells failed to bind the tetramer, suggesting that this population was heterogeneous with respect to the recognized epitope. We demonstrate that Tp250-59 represents a distinct epitope and that tetramers produced with Tp50-59 and Tp49-59 show no cross-reactivity. The Tp249-59 and Tp250-59 epitopes use different serine residues as the N-terminal anchor for binding to the presenting MHC I molecule. Molecular dynamic modelling predicts that the two peptide-MHC I complexes adopt structurally different conformations and Tcell receptor ß sequence analysis showed that Tp249-59 and Tp250-59 are recognized by non-overlapping T-cell receptor repertoires. Together these data demonstrate that although differing by only a single residue, Tp249-59 and Tp250-59 epitopes form distinct ligands for T-cell receptor recognition. Tetramer analysis of T. parva-specific CD8 T-cell lines confirmed the immunodominance of Tp1214-224 in BoLA-A18 animals and showed in BoLA-A10 animals that the Tp249-59 epitope response was generally more dominant than the Tp250-59 response and confirmed that the Tp298-106 response was subdominant.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Theileriosis / Subgrupos de Linfocitos T / Vacunas Antiprotozoos / Theileria parva / Linfocitos T CD8-positivos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Immunology Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Theileriosis / Subgrupos de Linfocitos T / Vacunas Antiprotozoos / Theileria parva / Linfocitos T CD8-positivos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Immunology Año: 2016 Tipo del documento: Article